← Leaderboards
Hans H. Herfarth
Univ Of North Carolina Chapel Hill
$10,539,519
Attributed
$10,539,519
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2007–18$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$10,539,519 · 5
By mechanism
U01$8,163,813 · 1
P01$1,590,421 · 1
R21$397,120 · 1
U34$388,089 · 1
M01$76 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Robert S Sandler$41,787,492
- Ryan Balfour Sartor$32,983,163
Others in their field
Top investigators on “S Disease”
- Lawrence Corey · Fred Hutchinson Cancer Center$643,566,627
- Jeffrey P Krischer · University Of South Florida$588,279,843
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$477,614,997
- David Heimbrook · Leidos Biomedical Research, Inc.$470,438,912
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$389,132,404
Research focus
S DiseaseResearch InfrastructureCrohn&AposOperative Surgical ProceduresProspectiveResearch PersonnelSamplingSerumExcisionIntestinesPlayBiopsySiteProtocols DocumentationResourcesAzathioprinePlacebo Controlled Study6-MercaptopurinePlacebosSafetyFreezingClinical PhenotypeFunctional GenomicsFamily Member
Grant awards (15)
Human Tissue and Genomics Core$160,838
P01 · FY2018 · DK · contact PI
Human Tissue and Genomics Core$304,411
P01 · FY2017 · DK · contact PI
Human Tissue and Genomics Core$290,403
P01 · FY2016 · DK · contact PI
MEthotrexate Response in Treatment of UC - MERIT-UC$1,543,652
U01 · FY2015 · DK · contact PI
Human Tissue and Genomics Core$290,403
P01 · FY2015 · DK · contact PI
MEthotrexate Response in Treatment of UC - MERIT-UC$1,548,877
U01 · FY2014 · DK · contact PI
Human Tissue and Genomics Core$290,403
P01 · FY2014 · DK · contact PI
MEthotrexate Response in Treatment of UC - MERIT-UC$1,571,446
U01 · FY2013 · DK · contact PI
Human Tissue and Genomics Core$253,963
P01 · FY2013 · DK · contact PI
MEthotrexate Response in Treatment of UC - MERIT-UC$1,670,502
U01 · FY2012 · DK · contact PI
MEthotrexate Response in Treatment of UC - MERIT-UC$1,829,336
U01 · FY2011 · DK · contact PI
Methotrexate Response In Treatment of UC$388,089
U34 · FY2009 · DK · contact PI
Pilot study on the safety and efficacy of ciprofloxacin for prophylactic preventi$214,620
R21 · FY2008 · DK · contact PI
CLINICAL TRIAL: CIPROFLOXACIN FOR PROPHYLACTIC PREVENTION OF POSTOPERATIVE ENDOS$76
M01 · FY2008 · RR · contact PI
Pilot study on the safety and efficacy of ciprofloxacin for prophylactic preventi$182,500
R21 · FY2007 · DK · contact PI